Clinical Trial Update: D-cycloserine for the Treatment of Chronic, Refractory Low Back Pain [Phase 2]

View source ↗

Summary

A Phase 2 trial studying D-cycloserine for chronic, refractory low back pain has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: Northwestern University | Conditions: Low Back Pain, Pain | Phase 2 | Status: TERMINATED